Members |
acceptabilityId |
[X]Anogenital herpes viral infection, unspecified |
Preferred (foundation metadata concept) |
[X]Anogenital herpes viral infection, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Anomalies of pupillary function in diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Anomalies of pupillary function in diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Antenatal screening for fetal growth retardation using ultrasonics and other physical methods |
Preferred (foundation metadata concept) |
[X]Antenatal screening for fetal growth retardation using ultrasonics and other physical methods (situation) |
Preferred (foundation metadata concept) |
[X]Antenatal screening for malformations using ultrasonics and other physical methods |
Preferred (foundation metadata concept) |
[X]Antenatal screening for malformations using ultrasonics and other physical methods (situation) |
Preferred (foundation metadata concept) |
[X]Anthrax, unspecified |
Preferred (foundation metadata concept) |
[X]Anthrax, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Anti-common-cold drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Anti-common-cold drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antiallergic and antiemetic drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antiallergic and antiemetic drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antiasthmatics causing adverse effects in therapeutic use, not elsewhere classified |
Preferred (foundation metadata concept) |
[X]Antiasthmatics causing adverse effects in therapeutic use, not elsewhere classified (disorder) |
Preferred (foundation metadata concept) |
[X]Anticholinesterase agents causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Anticholinesterase agents causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Anticoagulants causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Anticoagulants causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antidiarrheal drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antidiarrhoeal drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antidotes and chelating agents causing adverse effects in therapeutic use, not elsewhere classified |
Preferred (foundation metadata concept) |
[X]Antidotes and chelating agents causing adverse effects in therapeutic use, not elsewhere classified (disorder) |
Preferred (foundation metadata concept) |
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antigonadotrophins, antiestrogens, antiandrogens causing adverse effects in therapeutic use, not elsewhere classified (disorder) |
Preferred (foundation metadata concept) |
[X]Antigonadotrophins, antioestrogens, antiandrogens causing adverse effects in therapeutic use, not elsewhere classified |
Preferred (foundation metadata concept) |
[X]Antihelminthics causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antihelminthics causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antihyperlipidaemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antihyperlipidemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antimycobacterial drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antimycobacterial drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antineoplastic antimetabolites causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antineoplastic antimetabolites causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antineoplastic natural products causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antineoplastic natural products causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antipruritics causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antipruritics causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antirheumatics causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antirheumatics causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antispasticity drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antispasticity drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antithyroid drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antithyroid drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antitussives causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antitussives causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Antiviral drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Antiviral drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Anxiety disorder, unspecified |
Preferred (foundation metadata concept) |
[X]Anxiety disorder, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Anxiety hysteria |
Acceptable (foundation metadata concept) |
[X]Aortic aneurysm of unspecified site, nonruptured |
Preferred (foundation metadata concept) |
[X]Aortic aneurysm of unspecified site, nonruptured (disorder) |
Preferred (foundation metadata concept) |
[X]Aortic aneurysm of unspecified site, ruptured |
Preferred (foundation metadata concept) |
[X]Aortic aneurysm of unspecified site, ruptured (disorder) |
Preferred (foundation metadata concept) |
[X]Aortic valve disorders in diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Aortic valve disorders in diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Aortitis in diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Aortitis in diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Aplastic and other anaemias |
Preferred (foundation metadata concept) |
[X]Aplastic and other anemias (disorder) |
Preferred (foundation metadata concept) |
[X]Apocrine sweat disorder, unspecified |
Preferred (foundation metadata concept) |
[X]Apocrine sweat disorder, unspecified |
Preferred (foundation metadata concept) |
[X]Apocrine sweat disorder, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Apocrine sweat disorder, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Appetite depressants [anorectics] causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Appetite depressants [anorectics] causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Arenaviral haemorrhagic fever, unspecified |
Preferred (foundation metadata concept) |
[X]Arenaviral hemorrhagic fever, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Arthritis and polyarthritis due to other specified bacterial agents |
Preferred (foundation metadata concept) |
[X]Arthritis and polyarthritis due to other specified bacterial agents (disorder) |
Preferred (foundation metadata concept) |
[X]Arthritis in other infectious and parasitic diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Arthritis in other infectious and parasitic diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropathies in other endocrine, nutritional and metabolic disorders |
Preferred (foundation metadata concept) |
[X]Arthropathies in other endocrine, nutritional and metabolic disorders (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropathies in other specified diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Arthropathies in other specified diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropathy in hypersensitivity reactions classified elsewhere |
Preferred (foundation metadata concept) |
[X]Arthropathy in hypersensitivity reactions classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropathy in neoplastic disease classified elsewhere |
Preferred (foundation metadata concept) |
[X]Arthropathy in neoplastic disease classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropathy in other blood disorders classified elsewhere |
Preferred (foundation metadata concept) |
[X]Arthropathy in other blood disorders classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropod-borne viral encephalitis, unspecified |
Preferred (foundation metadata concept) |
[X]Arthropod-borne viral encephalitis, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Arthropod-borne viral fevers and viral haemorrhagic fevers |
Preferred (foundation metadata concept) |
[X]Arthropod-borne viral fevers and viral hemorrhagic fevers (disorder) |
Preferred (foundation metadata concept) |
[X]Arthrosis |
Preferred (foundation metadata concept) |
[X]Arthrosis (disorder) |
Preferred (foundation metadata concept) |